Thunen Shelley B's Form 4 filing
RxSight, Inc. (RXST) · filed Mar 5, 2024
- Accession no.
- 0000950170-24-025874
- Filed
- Mar 5, 2024
- Trade date
- Mar 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $563.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thunen Shelley BCIK 0001297491 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $15.60 | +$156,000 | 23,691 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −1,166 | $54.95 | −$64,071.7 | 22,525 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −6,361 | $56.38 | −$358,633.18 | 16,164 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −2,473 | $57.03 | −$141,035.19 | 13,691 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 56,805 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.